Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Gardner

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Clinical Psychopharmacology|February 23, 2023
Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control DisordersDavid M Gardner
The New York State Dental Journal|July 15, 2005
Platform switching as a means to achieving implant estheticsDavid M Gardner
Evidence-Based Mental Health|August 16, 2002
The addition of olanzapine to valproate or lithium for acute manic or mixed bipolar episodes reduced manic symptomsDavid M Gardner
Journal of Psychiatry & Neuroscience : JPN|September 26, 2002
Evidence-based decisions about herbal products for treating mental disordersDavid M Gardner
Dentistry Today|April 19, 2006
Maintaining crestal bone around dental implants: literature review and clinical techniqueDavid M Gardner
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 28, 2014
Competent psychopharmacologyDavid M Gardner
Dentistry Today|June 29, 2004
A case study for the predictable reconstruction of the hopeless maxillaDavid M Gardner
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|August 20, 2016
The immense value of qualitative research to pharmacyDavid M Gardner
CMAJ Open|December 9, 2014
Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive studyTamara Pringsheim, David M Gardner
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 22, 2008
Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled studyAmber Jennex, David M Gardner
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Psychopharmacology|February 23, 2023
Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control DisordersDavid M Gardner
The New York State Dental Journal|July 15, 2005
Platform switching as a means to achieving implant estheticsDavid M Gardner
Evidence-Based Mental Health|August 16, 2002
The addition of olanzapine to valproate or lithium for acute manic or mixed bipolar episodes reduced manic symptomsDavid M Gardner
Journal of Psychiatry & Neuroscience : JPN|September 26, 2002
Evidence-based decisions about herbal products for treating mental disordersDavid M Gardner
Dentistry Today|April 19, 2006
Maintaining crestal bone around dental implants: literature review and clinical techniqueDavid M Gardner
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 28, 2014
Competent psychopharmacologyDavid M Gardner
Dentistry Today|June 29, 2004
A case study for the predictable reconstruction of the hopeless maxillaDavid M Gardner
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|August 20, 2016
The immense value of qualitative research to pharmacyDavid M Gardner
CMAJ Open|December 9, 2014
Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive studyTamara Pringsheim, David M Gardner
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 22, 2008
Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled studyAmber Jennex, David M Gardner
Pageof 7